119 related articles for article (PubMed ID: 8150764)
1. A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
Gouin F; Papazian L; Martin C; Albanese J; Durbec O; Domart Y; Veyssier P; Leroy J; Grès JJ; Rollin C
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():205-14. PubMed ID: 8150764
[TBL] [Abstract][Full Text] [Related]
2. Low-dosage cefepime as treatment for serious bacterial infections.
Giamarellou H
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():123-32. PubMed ID: 8150755
[TBL] [Abstract][Full Text] [Related]
3. A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections.
Mouton Y; Chidiac C; Humbert G; Leroy J; Veyssier P; Modai J; Bertrand A; Dellamonica P; Micoud M; Stahl JP
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():133-40. PubMed ID: 8150757
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
Holloway WJ; Palmer D
Am J Med; 1996 Jun; 100(6A):52S-59S. PubMed ID: 8678098
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients.
Chaudhary M; Shrivastava SM; Varughese L; Sehgal R
Curr Clin Pharmacol; 2008 May; 3(2):118-22. PubMed ID: 18700304
[TBL] [Abstract][Full Text] [Related]
6. [Phare study. Comparative study of combined cefepime-amikacin versus ceftazidime combined with amikacin in the treatment of nosocomial pneumonias in ventilated patients. Multicenter group study].
Beaucaire G; Nicolas MH; Martin C; Offenstadt G; Philippon A; Holzapfel L; Péan Y; Léophonte P; Le Fur D; Renard S
Ann Fr Anesth Reanim; 1999 Feb; 18(2):186-95. PubMed ID: 10207592
[TBL] [Abstract][Full Text] [Related]
7. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
Dubois V; Arpin C; Melon M; Melon B; Andre C; Frigo C; Quentin C
J Clin Microbiol; 2001 Jun; 39(6):2072-8. PubMed ID: 11376037
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
Covi M; Velluti G
J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
[TBL] [Abstract][Full Text] [Related]
9. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
[TBL] [Abstract][Full Text] [Related]
10. A multicenter comparative study of cefepime versus broad-spectrum antibacterial therapy in moderate and severe bacterial infections.
Badaró R; Molinar F; Seas C; Stamboulian D; Mendonça J; Massud J; Nascimento LO;
Braz J Infect Dis; 2002 Oct; 6(5):206-18. PubMed ID: 12495602
[TBL] [Abstract][Full Text] [Related]
11. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
Colardyn F
J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
[TBL] [Abstract][Full Text] [Related]
13. Cefepime versus cefotaxime in the treatment of lower respiratory tract infections.
Barckow D; Schwigon CD
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():187-93. PubMed ID: 8150762
[TBL] [Abstract][Full Text] [Related]
14. International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections.
Hoepelman AI; Kieft H; Aoun M; Kosmidis J; Strand T; Verhoef J; Gillespie SH; Riddell J; Varghese G; Meunier F
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():175-86. PubMed ID: 8150761
[TBL] [Abstract][Full Text] [Related]
15. Cefepime as treatment for osteomyelitis and other severe bacterial infections.
Jauregui L; Matzke D; Scott M; Minns P; Hageage G
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():141-9. PubMed ID: 8150758
[TBL] [Abstract][Full Text] [Related]
16. Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
Mouton YJ; Beuscart C
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():145-56. PubMed ID: 8543490
[TBL] [Abstract][Full Text] [Related]
17. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infections.
Léophonte P; Bertrand A; Nouvet G; Muir JF; Lucht F; Delaval P; Depierre A; Hughes F; Ulmer M; Grès JJ
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():165-73. PubMed ID: 8150760
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
Beaucaire G
J Chemother; 1995 Jun; 7 Suppl 2():165-73. PubMed ID: 8622107
[TBL] [Abstract][Full Text] [Related]
20. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]